ABSTRACT
Gly-292 --Ser mutation and a frameshift mutation at Arg-484 (GG --C) were identified in patients with severe steroid 21-hydroxylase deficiency. An allele with three additional sequence variations-C -> T at 4 bases upstam oftra tion initiation, Pro-106 -* Len, and Pro-454 -+ Ser-were identified in two sings with late-nset deficiency. Pro (1, 2) . Steroid 21-hydroxylase deficiency is inherited as an autosomal recessive trait. The disorder exists in a wide range of manifestations that traditionally have been divided into three groups: (i) simple virilizing, presenting with virilization of external genitalia at birth in girls and early pseudoprecocious puberty in boys; (ii) salt-wasting, which in addition shows severe aldosterone deficiency neonatally; and (iii) late-onset, which is associated with pseudoprecocious puberty, hirsutism, polycystic ovary syndrome, and decreased fertility (3) (4) (5) . However, the three groups are not distinct. The severe forms of the disease occur in 1/12,000 Swedish newborns. Based on hormonal analyses, mild steroid 21-hydroxylase deficiency is estimated to occur in 1/500-1/1000 North Europeans (6) .
There are two human steroid 21-hydroxylase genes (210H)-one active gene, CYP21, and a highly homologous inactive pseudogene, CYP2JP. These genes are located 3' of each of the two genes encoding the fourth component of complement, C4A and C4B, in the HLA class III gene region on chromosome 6p21.3 (7, 8) , forming tandem repeat units. Considerable variation in the number and gross structure of C4/210H repeat units has been detected (9, 10) . The CYP21 gene consists of 10 exons spanning 3 kilobases (kb) of DNA (11) (12) (13) . Studies of upstream sequences in mice have identified a number of potential regulatory elements within 300 base pairs (bp) 5 ' of the gene that influences gene expression in vitro (14) . Considerable sequence variation has been described between human CYP21 genes, some altering the encoded steroid 21-hydroxylase protein sequence. The protein variants include both apparently neutral amino acid substitutions (11-13, 15, 16) , as well as substitutions causing impairment of steroid 21-hydroxylase activity (15, (17) (18) (19) (20) (21) (22) . All described sequence variants that impair enzyme function are also present in the pseudogene and are thought to be transferred by recombination from CYP2JP to CYP21. The pseudogene-derived mutations represent a large part but do not represent all of the steroid 21-hydroxylase deficiency mutations in different populations (16, 21, 23) .
Attempts to fully characterize the genetic lesions in the various manifestations of steroid 21-hydroxylase deficiency have been hampered by the complicated structure of the CYP21 locus. We have developed rapid direct sequencing of selectively PCR-amplified full-length CYP21 genes to obtain information ofall nonpseudogenes present in individuals with various disease manifestations. This technique enabled identification of three additional mutated alleles and establishment of genotype-phenotype correlations for the common mutations. The functional contribution of individual CYP21 alleles has been determined in vivo by studying subjects carrying only one copy of the gene (hemizygous).
MATERIALS AND METHODS
Patients. The study comprises 2 healthy controls and 34 patients affected with steroid 21-hydroxylase deficiency of different severity. This group represents 61 unrelated alleles. The main symptoms and the time of their initial observation are given in Table 1 . Urine from four patients-B32, B33, B103, and B108-carrying three additional mutated alleles, were collected over a 24-hr period, and the steroid pattern was analyzed by using gas/liquid chromatography, displaying typical increases of pregnanetriol. There were no metabolites suggesting any other defect in adrenal steroidogenesis. In addition, patients B32 and B33 showed pathological responses of serum cortisol and 17-hydroxyprogesterone concentrations during an adenocorticotropic hormone (ACTH) test (10) . Two individuals hemizygous for the CYP21 gene, B21 and B31, exhibited normal hormone levels during the ACTH test. The C4/210H haplotypes of the patients have previously been characterized and are given in Table 1 (10, 24) . Haplotypes 1 and 2 contain one CYP21P and one CYP21 gene, haplotype 5 contains only one CYP21, and haplotypes 6, 7, and 8 contain two CYP21P and one CYP21 (Fig. 1) . Linkage phases of haplotypes and mutations were established through segregation in families. The study was approved by the Ethics Committee at the Karolinska Hospital.
PCR. Genomic DNA was prepared from peripheral leukocytes. A specific restriction site for Taq I is present at base -210 in the CYP21P gene (Fig. 1) , base numbering being identical to that reported by Rodrigues et al. (13) . In cases where the CYP21 alleles were completely sequenced from nucleotides -330 to 2735, DNA was cleaved with Taq I (New England Biolabs), and a first round of PCR was done by using primers P1 5'-TTCAGGCGATTCAGGAAGGC (-418 to -399) and P4 5'-TCTCGCACCCCAGTATGACT (2892-2911) at concentrations of 0.5 ILM (Fig. 1) 30 sec, and 72°C for 3 min in 100 ,l, using one normal and one biotinylated primer at 0.1 ,uM. Taq polymerase (PerkinElmer/Cetus) was used at 2 units per 100 ,lI. For partially sequenced alleles, the first round of PCR was performed by using primers P1 together with P48 (5'-CAGAGCAGGGAG-TAGTCTC) and P55 (5'-CCTGTCCTTGGGAGACTACT) together with P4 ( Fig. 1) . Primers P48 and P55 are specific for the sequence in nonpseudogene DNA; P49 covers the corresponding part in the pseudogene containing an 8-bp deletion. To verify the specificity in distinguishing between CYP21 and CYP2JP, all DNAs were amplified with primers P48 and P49 together with P1, and the produced fragments were submitted to Taq I cleavage. In all cases only genes carrying the deletion were cleaved. Allele-specific PCR was performed from one patient (B108), where a previously unreported mutation was found in heterozygous form. Her CYP21 alleles were followed by segregation from the parents, and a heterozygous position (base 1126) was used to design C4A CYP21P C4B CYP21 a primer with the most-3' nucleotide base-pairing only with the allele carrying the additional mutation.
Direct Sequencing. The biotinylated PCR fragments were immobilized by binding to streptavidin-covered magnetic beads (Dynabeads; Dynal, Oslo), and the nonbiotinylated strands were removed by incubating in 50 pl of 0.15 M NaOH for 5 min at room temperature (25) . The remaining DNA was rinsed three times, suspended in 13 1.L of distilled water, and sequenced by the dideoxynucleotide chain-termination method with the Auto-Read sequencing kit (Pharmacia). Sequencing was done with fluorescently labeled primers by using the Pharmacia automated laser fluorescent DNA sequencer. Thirteen out of 43 alleles were completely sequenced from nucleotides -330 to 2735. The remaining alleles were partly sequenced. Additional mutations were confirmed by sequence determination of both strands. All primer sequences for PCR amplification and DNA sequence determination are available upon request.
RESULTS
Hemizygous Individuals. The CYP21 alleles from two hemizygous individuals with normal steroid 21-hydroxylase function were completely sequenced from base -330 to base 2735. Patient B21 differed from patient B31 in four silent positions in exons and seven positions in introns (Table 1 ). In addition, this normal allele varied at base 1650, changing Ser-269 to threonine.
Twenty hemizygous patients with steroid 21-hydroxylase deficiency were analyzed (Table 1) . Patient B103, affected with salt-wasting disease, carried an allele with a previously unreported G -* A transition at nucleotide 1718, changing Gly-292 -+ Ser in exon 7 ( Fig. 2A) . The only additional sequence variation between bases -330 and 2735, as compared with the two normal alleles, was a T -> C transition at position 398, 9 bases into the 5' end of intron 2. Two siblings affected with late-onset disease (B32, B33) carried three additional base substitutions in their only CYP21 allele. These include a C -) T transition at 4 bases upstream of the initiation codon; a C --T transition at nucleotide 696, changing Pro-106 to leucine in exon 3; and a C -* T transition at position 2584, changing Pro-454--Ser in exon 10 (Fig. 2B) .
No other deviations from the normal alleles were detected.
Of the remaining hemizygous patients, seven (B14, B20, B60, B74, B100, B110, and B115) carried the splice mutation at base 659 located 13 bp upstream of exon 3 (16, 17) , one CYP21 allele (B68) carried the Arg-357 -* Trp mutation at base 2113 (15) , and one CYP21 allele (B80) carried the thymine insertion at base 1768, creating a truncated protein.
The Val-282 -+ Leu mutation at base 1688 (19) was identified in three patients (B57, B85, and B92). Five CYP21 alleles from hemizygous patients carried the Ile-173 -> Asn mutation (18) at base 1004 (B28, B37, B41, B73, and B101). Three Asn-173 alleles were completely sequenced from patients with different disease manifestations (B37, B73, and B101). Table 1 shows that only base 2252 differed among the alleles, resulting in a silent codon change at Ser-375.
Heterozygous Individuals. Fourteen steroid 21-hydroxylase deficiency patients carrying two CYP21 genes on known C4/210H haplotypes were sequenced. One heterozygous patient with severe steroid 21-hydroxylase deficiency (B108) carried the Arg-357--Trp mutation on one chromosome, and a totally different mutation on the other. Bases 2675-2676, coding for GG in Arg-484 in exon 10, were replaced by cytosine, causing a frameshift and resulting in a predicted 45-amino acid-longer protein with 57 additional amino acids in the C-terminal end. This allele also carried the Asp-184 -+ Glu mutation at base 1126, which has been shown to encode an enzyme with normal function after transfection in vitro (16) . The only other sequence variation was a T -* C Medical Sciences: Wedell et al. Fig. 1 (10) . For heterozygous patients, mutations are assigned to corresponding haplotypes by their placement relative to the comma. *Nucleotide 1 is the adenosine in the start codon, 5' denotes the 5' untranslated region, E and I denote exons and introns, and the amino acids in one-letter code are given for B31 at the polymorphic positions. §Patient B4 was identified by hormonal analysis before symptom onset; patients B20, B37, and B115 received hormonal substitution before developing clear salt-wasting; patients B51, B84, and B101 were virilized from birth but were not diagnosed until the indicated age; patient B85 showed salt-wasting during a gastrointestinal infection, but treatment was terminated at 2 yr (10) .
transition at position 398, 9 bases into the 5' end of intron 2, the same as in allele B103 ( Table 1 ). The GG --* C frameshift mutation at Arg-484 is shown in heterozygous form (Fig. 2C) , as well as after allele-specific PCR and sequencing (Fig. 2D ).
Five patients (B44, B64, B65, B82, and B121) were homozygous for the splice mutation at base 659. Three patients (B4, B51, and B84) were heterozygous for the splice mutation and the Ile-173 --+ Asn mutation. Four patients (B46, B48, B112, and B126) were heterozygous for the splice mutation at base 659 and the Val-282 --> Leu mutation. One patient (B47) was homozygous for the Val-282 --+ Leu mutation. An example of the DNA sequence covering the splice mutation at base 659 in heterozygous form is shown in Fig. 2E (15-19, 26, 27) . All these variants have been seen in the sequence of at least two of the three reported CYP2JP alleles. Other positions that varied among the CYP2J alleles include 11 intron substitutions, 6 silent codon substitutions, and 5 sequence variations leading to amino acid changes (deletion of Leu-10, Arg-103 --i Lys, Asp-184 --+ Glu, Ser-269 --+ Thr, and Ser-494 --* Asn). These amino acid changes have been seen in the four normal alleles reported by others and/or have resulted in normal enzyme activity after transfection (11-13, 15, 16, 28 phisms are also present in alleles reported normal by others (11, 12) . The remaining 2 variations in intron 2, bases 398 and 605, have not been excluded as affecting gene expression.
The variation at base 398 is present on our two additional severely affected alleles (B103, B108) and has also been seen together with the splice mutation (17) and the Gln-319 --. stop mutation (20) . The variation at position 605 is present in an allele also carrying the 659 splice mutation (B20). Arg-484 -* frameshift B108 between human (11, 12) , bovine (29, 30) , murine (31) , and porcine (32) steroid 21-hydroxylases, indicating its importance for normal enzyme function. The only additional base variation in this allele, which has not been demonstrated as neutral with regard to steroid 21-hydroxylase activity, is a T --C transition at base 398, 9 bases into the 5' end of intron 2. This nucleotide is unlikely to be important for the function of the allele, considering its location outside the consensus sequence in the 5' end of introns (33) . Three positions in the CYP21 allele of the hemizygous siblings, B32 and B33, deviated from the normal sequence, nucleotide -4, Pro-106 --Leu, and Pro-454 --Ser. Pro-454 is conserved among human, bovine, murine, and porcine steroid 21-hydroxylases, which makes this amino acid substitution the most likely candidate for causing the mild, late-onset deficiency ofthese patients. Pro-106 does not show this species conservation. As long as a purine is located at position -3, deviations from the rest of the consensus sequence surrounding the AUG codon only slightly impair the initiation of translation (34) , making the base variation at -4 an unlikely candidate.
DISCUSSION
A frameshift mutation, GG --C at Arg-484, was found in patient B108. This patient is a compound heterozygote for this mutation and the Arg-357 -* Trp mutation and showed symptoms of salt-wasting at 3 weeks of age. The allele with the frameshift mutation at position 2675 also carried the variation at base 398, 9 bases into the 5' end of intron 2, which has not been excluded as affecting enzyme function. However, the predicted protein resulting from the frameshift mutation is 45 amino acids longer than the normal enzyme, making severe disruption of activity conceivable.
Eighteen of the 59 unrelated steroid 21-hydroxylase deficiency alleles carried a deletion of the entire CYP21 gene. Of the abnormal nondeletion CYP21 alleles, three base substitutions-the splice mutation at base 659, Ile-173 -> Asn, and Val-282 --Leu-were identified in 35 out of 41 alleles (85%). One additional mutation, Arg-357 -* Trp, occurred in more than one allele. These findings show no major deviation from results obtained in other populations (16, 21, 23) .
Sequencing the complete CYP21 allele of individuals hemizygous for this gene enabled evaluation of the contribution of individual polymorphisms with regard to steroid 21-hydroxylase function in vivo. The Ser-269 --Thr substitution at 1650 has been shown to result in normal enzyme activity after transfection in vitro (16) but has only been found in vivo in heterozygous form (35) . Its presence in individual B21 confirmed that this amino acid substitution is neutral with regard to 21-hydroxylase deficiency. Six intron variations (positions 562, 1109, 1116, 1425, 1426, and 1562) were also assigned as neutral in this way. Similarly, correlations between genotype and phenotype could be made. Deletion of CYP21 obviously leads to abolished enzyme function, which correlated with salt-wasting. The splice mutation at base 659 was associated with neonatal salt-wasting, except in one case. In two siblings homozygous for this mutation (B64 and B65), the elder was raised as a boy until 3 yr of age when he was diagnosed as a severely virilized girl, whereas the younger brother showed severe neonatal salt-wasting. In none of the other 11 patients who were hemi-or homozygous for this mutation could neonatal salt-wasting be excluded. This mutation has been shown to have low, but measurable, in vitro activity after transfection (16 (10) . The Ile-173 -+ Asn mutation has been described as displaying the largest degree of clinical variation, the clinical spectrum ranging from late-onset to salt-wasting (16, 18, 21 Association has previously been observed between mild 21-hydroxylase deficiency and haplotypes with three C4/ 210H repeat units (10, 24, 36, 37) . All 7 Val-282 -+ Leu mutations occurred on the two nonidentical triplicated C4/ 210H haplotypes 6 or 7 (Fig. 1) 
